Decoy Therapeutics (DCOY) Receivables (2016 - 2023)
Decoy Therapeutics (DCOY) posted quarterly Receivables of $130000.0 for Q2 2023, down 91.88% year-over-year from $1.6 million in Q2 2022, and up 109.63% quarter-over-quarter from -$1.4 million in Q1 2023.
Decoy Therapeutics (DCOY) Receivables (2016 - 2023) Analysis & Trends
Decoy Therapeutics (DCOY) has reported Receivables for 8 consecutive years, with $130000.0 the latest figure, recorded in Q2 2023.
- In Q2 2023, Receivables fell 91.88% year-over-year to $130000.0; the TTM figure through Jun 2023 stood at $130000.0 (down 91.88% YoY), while the FY2023 annual figure was -$1.5 million, down 191.93% from the prior year.
- Receivables grew to $130000.0 in Q2 2023 per DCOY's latest filing, from -$1.4 million in the prior quarter.
- Across five years, Receivables topped out at $5.4 million in Q2 2021 and bottomed at -$1.4 million in Q1 2023.
- Historically, Receivables has averaged $1.7 million across 5 years, with a median of $1.6 million in 2022.
- Annual changes were most pronounced in 2020 — Receivables surged 12936.26% — and 2023, when it sank 184.41%.
- Decoy Therapeutics' Receivables stood at $28278.0 in 2019, then surged by 15811.01% to $4.5 million in 2020, then slumped by 110.57% to -$475667.0 in 2021, then jumped by 438.58% to $1.6 million in 2022, then slumped by 91.93% to $130000.0 in 2023.
- Business Quant data shows DCOY's Receivables at $130000.0 in Q2 2023, -$1.4 million in Q1 2023, and $1.6 million in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | - |
| 10 | Decoy Therapeutics | 1.82 Mn | 1.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 130,000.00 |
| Mar 31, 2023 | -1.35 Mn |
| Dec 31, 2022 | 1.61 Mn |
| Sep 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | 1.60 Mn |
| Dec 31, 2021 | -475,667.00 |
| Sep 30, 2021 | -608,762.00 |
| Jun 30, 2021 | 5.37 Mn |
| Mar 31, 2021 | 4.59 Mn |
| Dec 31, 2020 | 4.50 Mn |
| Sep 30, 2020 | 4.59 Mn |
| Jun 30, 2020 | 3.08 Mn |
| Mar 31, 2020 | 1.18 Mn |
| Jun 30, 2019 | 28,278.00 |
| Mar 31, 2019 | 9,069.00 |
| Dec 31, 2018 | 9,939.00 |
| Sep 30, 2018 | 20,993.00 |
| Jun 30, 2018 | 17,329.00 |
| Mar 31, 2018 | 12,631.00 |